Coastal Digestive Health | Maroochydore, Australia
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have a body mass index (BMI) ≥35.0 kilogram/square meter (kg/m²).
Have established cardiovascular (CV) disease with at least 1 of the following:
Have a history of at least 1 self-reported unsuccessful dietary effort to reduce body weight.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,800 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
There may be multiple sites in this clinical trial -877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal